Cresco Labs Opens 83rd Dispensary in Kentucky
Cresco Labs opened its 83rd U.S. dispensary, Sunnyside Prestonsburg, in eastern Kentucky, marking the first time medical cannabis dispensaries operate in all 11 regions of the state. The location sits at 81 Glynview Plaza in Prestonsburg. It provides in-store and online pickup options via sunnyside.shop for registered patients.
Opening Brings Medical Cannabis to All Kentucky Regions
The grand opening represents a milestone for Kentucky’s emerging medical cannabis program. Patients in the eastern part of the state now have access to a new retail option.
Charlie Bachtell, CEO of Cresco Labs, said in a statement that “access is the foundation of any successful medical cannabis program.” He added that Kentucky continues to make meaningful progress and that the company is excited to help build on that momentum.
The dispensary offers an education-focused shopping experience with trained Wellness Advisors available to assist patients. Products include flower for vaporization, tinctures, topicals, and edibles, all lab-tested.
Product Range and Patient Services
Sunnyside Prestonsburg joins Cresco Labs’ national network of dispensaries operating under the Sunnyside brand. The company emphasizes building patient and consumer trust through education and convenience.
Read Also: Quebec mine turns phosphate waste into saleable calcium carbonate
National Expansion and Brand Portfolio
Cresco Labs operates dispensaries nationwide and manages several brands including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s, and Remedi.
The company’s mission focuses on normalizing and professionalizing the cannabis industry through branded product distribution and customer-focused retail experiences. Cresco Labs also engages in year-round policy work, community outreach, and workforce development initiatives.
Forward-looking statements in the announcement caution that actual results may differ from expectations due to risks and uncertainties discussed in the company’s Annual Information Form for the year ended December 31, 2025, filed with Canadian securities regulators and EDGAR.
Regulatory Context and Future Outlook
The expansion into all 11 Kentucky regions follows the state’s ongoing rollout of its medical cannabis framework. Cresco Labs noted its commitment to supporting communities through authentic engagement and legislative initiatives.
The company stated it does not intend to update forward-looking information contained in the announcement, which speaks as of the date of issuance. This opening adds to Cresco Labs’ presence across multiple states where medical cannabis remains legal under state law.
